FAQs

Using Neteera 130H-Plus is beneficial for all stakeholders: Physicians and nurses can remotely monitor their patients from their offices or nurse stations and receive vitals in real time. Patients can be monitored from the comfort of their home their room in a skilled nursing facility, or in hospital wards without cumbersome wires and cables.

Using Neteera 130H-Plus has many advantages, including: Less time spent on collecting data manually Automated data upload to ADT/EHR/EMR platforms Early detection & trend analysis help focus on patients in need Continuous monitoring of patients Preventive care & fast response No consumables & no maintenance

All that is required to use Neteera 130H-Plus is Wi-Fi connectivity and access to electricity. Clinicians can observe vital signs on Neteera’s dashboard through a smartphone, tablet, or computer.

A secured Wi-Fi internet connection is used to transmit data. Data is sent via an encrypted secure network and stored on our HIPAA and GDPR-compliant cloud platform. Email and password authorizations are used to view the dashboard with patient vital signs.

Neteera 130H-Plus measures micro-skin displacements caused by heartbeats and respiration in a contactless manner. The derived signal, the ballistocardiogram correlates accurately with standard ECG signals.

Neteera 130H Plus Vital Sign Monitoring Sensor is FDA 510(k) Class II medical device, cleared for spot and continuous measurement of heart rate and respiration rate.

Neteera takes personal health information and sensitive data privacy and confidentiality very seriously. In addition to other measures we are taking, Neteera is HIPAA & GDPR-compliant.

Data is stored on our HIPAA and GDPR-compliant cloud platform.

The collected data is accessed via API with the Neteera Cloud, enabling seamless integration into existing workflows.

The accuracy of Neteera 130H-Plus was determined by performing extensive clinical studies that were submitted and approved by the FDA.

Neteera 130H-Plus is not a wearable device. It is contactless, and accurately measures vital signs from a distance and there is no need to remove clothing.

Neteera 130H-Plus measures heart rate and respiratory rate.

Since Neteera 130H Plus is contactless, removal of clothing is not required and not necessary. Your dignity and integrity are not compromised.

Currently, Neteera 130H-Plus works up to a distance of 8 ft. or 1.5 m.

Neteera 130H-Plus is the world’s first and only fully industrial sub-THz radar on chip established and developed in house. The high frequency enables unrivaled data accuracy and the ability to develop and add future parameters on the same platform.

Warnings and Precautions: Use only the accessories and parts supplied with the Neteera device. Should a part or accessory require replacement, please contact Neteera support at support@neteera.com. Do not attempt to replace parts or accessories without prior consultation with Neteera support. The monitored person should not share the chair with another person or pet, as this could affect the system's effectiveness and the accuracy of the measurements. If the monitored person is sharing the bed with another person or pet, the device should be mounted to the wall (bed head) and shifted ~50cm outside from the middle of the subject’s bed to ensure the effectiveness of the system and the accuracy of the measurements. Avoid using heated blankets, or any other metal-containing heating item located between the Neteera device and the monitored person. The use of heating blankets could affect the effectiveness of the Neteera device and void the system’s warranty. The monitored person should not have direct contact with the Neteera device – a minimum distance of 5 cm should be maintained. The Neteera device is not intended to be a replacement for monitoring high-risk situations where ECG/Capnograph monitoring is used. The Neteera technology and parameters have not been studied on any specific monitored person or group, nor has it been studied as a diagnostic tool for any specific disease or medical condition. It is meant to be an adjunctive tool only for measuring respiratory rate and heart rate. The device has not been validated in a pediatric population and in individuals with arrhythmia. The device is not intended for ambulatory conditions. As with all medical equipment, carefully route and secure Neteera device cables and connections to reduce the possibility of entanglement or strangulation. Interconnection of this equipment to other equipment not described in the instructions for use is prohibited. The Neteera monitoring system is not intended to be used as an alarm system for potentially life-threatening situations in which medical intervention is necessary. The device is not intended to be used as a real-time monitor or apnea monitor for immediate action. Do not rely on the respiration monitoring for detection of cessation of breathing and always follow hospital guidelines and best clinical practices, including monitoring additional parameters that indicate the patient’s oxygenation status. Prior to delivering medical treatment based on a high heart rate reading (120 to 160 bpm), the subject should be asked to remain still for several minutes to allow the reading to be verified under no motion conditions.